TNF antagonist therapy for gastrointestinal acute graft-versus-host disease refractory to steroid in allogeneic haematopoietic cell transplantation

被引：0

作者：

Shimazu, H. ^{[1
]}

Tsuji, M. ^{[1
]}

Ishiwata, K. ^{[1
]}

Nakano, N. ^{[1
]}

Yamamoto, H. ^{[1
]}

Asano-Mori, Y. ^{[1
]}

Uchida, N. ^{[1
]}

Masuoka, K. ^{[1
]}

Wake, A. ^{[1
]}

Makino, S. ^{[1
]}

Yoneyama, A. ^{[1
]}

Taniguchi, S. ^{[1
]}

机构：

[1] Toranomon Gen Hosp, Tokyo, Japan

来源：

BONE MARROW TRANSPLANTATION | 2010年 / 45卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S390 / S390

页数：1

共 50 条

[31] Extracorporeal photochemotherapy treatment of steroid refractory or hyperacute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation from matched unrelated donors [J].

Reti, M. ;

Remenyi, P. ;

Barta, A. ;

Batai, A. ;

Csukly, Z. ;

Goda, V. ;

Gopcsa, L. ;

Lengyel, L. ;

Rasonyi, R. ;

Torbagyi, E. ;

Masszi, T. .

BONE MARROW TRANSPLANTATION, 2012, 47 :S159-S159

[32] Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease [J].

Mehta, Rohtesh S. ;

Saliba, Rima M. ;

Jan, Anna ;

Shigle, Terri Lynn ;

Wang, Emily ;

Nieto, Yago ;

Ciurea, Stefan O. ;

Oran, Betul ;

Im, Jin ;

Olson, Amanda ;

Marin, David ;

Qazilbash, Muzaffar ;

Khouri, Issa ;

Rondon, Gabriela ;

Anderlini, Paolo ;

Rezvani, Katayoun ;

Popat, Uday ;

Kebriaei, Partow ;

Shpall, Elizabeth ;

Champlin, Richard ;

Alousi, Amin .

TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03) :272.e1-272.e5

[33] Computed tomography imaging of acute gastrointestinal graft-versus-host disease after haematopoietic stem cell transplantation in children [J].

Arpaci, Taner .

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2018, 22 (03) :178-183

[34] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation [J].

Massenkeil, G ;

Rackwitz, S ;

Genvresse, I ;

Rosen, O ;

Dörken, B ;

Arnold, R .

BONE MARROW TRANSPLANTATION, 2002, 30 (12) :899-903

[35] Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation [J].

G Massenkeil ;

S Rackwitz ;

I Genvresse ;

O Rosen ;

B Dörken ;

R Arnold .

Bone Marrow Transplantation, 2002, 30 :899-903

[36] Tacrolimus versus cyclosporine A in prophylaxis of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia [J].

Stankevich, Y. ;

Zubarovskaya, L. ;

Vavilov, V. ;

Bondarenko, S. ;

Darskaya, E. ;

Kulagin, A. ;

Afanasyev, B. .

BONE MARROW TRANSPLANTATION, 2012, 47 :S153-S154

[37] HLA allele associations with graft-versus-host disease following allogeneic haematopoietic stem cell transplantation [J].

Kitra, V ;

Moraloglou, O ;

Petra, F ;

Spanou, K ;

Peristeri, I ;

Gousetis, E ;

Delikou, S ;

Constantinidou, N ;

Graphakos, S .

BONE MARROW TRANSPLANTATION, 2005, 35 :S137-S138

[38] Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation [J].

Yamane, T ;

Yamamura, R ;

Aoyama, Y ;

Nakamae, H ;

Hasegawa, T ;

Sakamoto, C ;

Shibata, H ;

Terada, Y ;

Koh, G ;

Hino, M .

LEUKEMIA & LYMPHOMA, 2003, 44 (12) :2095-2097

[39] Clinical aspects of sclerodermoid type graft-versus-host disease after allogeneic haematopoietic cell transplantation [J].

Sanly, H ;

Akay, N ;

Soydan, E ;

Kocyigit, P ;

Arat, M ;

Ilhan, O .

BONE MARROW TRANSPLANTATION, 2006, 37 :S96-S96

[40] Graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in children and adolescents with thalassemia [J].

Pakakasama, S. ;

Klamchuen, S. ;

Hongeng, S. ;

Sirireung, S. ;

Anurathapan, U. ;

Songdej, D. ;

Sasinil, S. ;

Sirachainan, N. ;

Chuansumrit, A. .

BONE MARROW TRANSPLANTATION, 2013, 48 :S285-S285

← 1 2 3 4 5 →